Article
Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
The American journal of gastroenterology - 1 Dec 1991
Motojima K, Urano T, Nagata Y, Shiku H, Tsunoda T, Kanematsu T
Abstract excerpt
Utilizing the polymerase chain reaction (PCR), we studied the presence and pattern of mutations in the Kirsten (Ki)-ras oncogene, using paraffin-embedded sections of pancreatic carcinoma tissue from 53 patients. Mutations in the Ki-ras oncogene were evident in 46 of the 53 patients (87%) in codon 12. The predominant mutation was from glycine (GGT) to aspartic acid (GAT). Among the 46, one had an additional...
Topics
- Adenocarcinoma
- Aged
- Cystadenocarcinoma
- Female
- Genes, ras
- Humans
- Male
- Middle Aged
- Mutation
- Neoplasm Staging
- Nucleic Acid Hybridization
